Quick Dispatch:
Your semaglutide drug shortage list Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your semaglutide drug shortage list Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s ships.
Need Help?
Questions about semaglutide drug shortage list Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for semaglutide drug shortage list Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s in your area.
FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic Over
28.94
Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on notice
21.18
As of February 21, 2025, the FDA updated its drug shortage list, marking the semaglutide injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A
22.36
The FDA has removed semaglutide injection products (GLP-1) from the shortage list, ending the temporary rule that allowed pharmacies to compound these medications, often used for weight loss. Compounded drugs are custom-made
20.76
Semaglutide Injections and the FDA
29.45
US FDA says two more doses of Novo Nordisk's weight-loss drug now available
29.28
As of February 21, 2025, the FDA updated its drug shortage list, marking the semaglutide injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A
23.23
